Viking Therapeutics, Inc. (VKTX)
33.23
-0.66
(-1.95%)
USD |
NASDAQ |
Aug 24, 16:00
33.55
+0.32
(+0.96%)
After-Hours: 06:08
Viking Therapeutics Gross Profit Margin (Quarterly)
Gross Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Gross Profit Margin (Quarterly) Data
| Date | Value |
|---|
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Gross Profit Margin (Quarterly) Benchmarks
| Vertex Pharmaceuticals, Inc. | 85.37% |
| Eli Lilly & Co. | 85.78% |
| Regeneron Pharmaceuticals, Inc. | 83.68% |
| Skye Bioscience, Inc. | -- |
| Eledon Pharmaceuticals, Inc. | -- |
Gross Profit Margin (Quarterly) Related Metrics
| Return on Equity | -87.45% |
| Return on Assets | -78.34% |
| Return on Invested Capital | -87.28% |
| Return on Net Operating Assets | -3.77K% |